NSW continues to drive innovation in medical research
The NSW Government continues to advance medical research in NSW through investment in the 2016-17 Budget.
Minister for Medical Research Pru Goward said quality medical research leads to a greater knowledge, understanding and better health outcomes for the people of NSW.
"The 2016-17 Budget continues to invest in vital medical research which will fundamentally change the way health care is delivered in the future, with a focus on individualised treatments and prevention," Goward said.
Key health and medical research initiatives in the 2016-17 NSW Budget include:
- $44.5 million for the Medical Research Support Program to support 15 independent medical research institutes
- $9.75 million over four years to advance new health care technology and devices through the Medical Devices Fund and other commercialisation initiatives
- $7 million to embed translational research into clinical practice in NSW hospitals and LHDs through the Health Services Research Support Program including the Translational Research Grants Scheme
- $6 million to unlock the causes of some of the most debilitating genetic conditions through the Genomics Collaborative Grants Program
- $3 million for our three medical cannabis clinical trials for children with severe drug resistant epilepsy, people in palliative care and people with chemotherapy induced nausea and vomiting
- $2.5 million to support the development of the next generation of medical researchers in NSW, through the Early-Mid Career Fellowship Scheme and PhD Scholarships.
Have your say...
The approval of your comment is at the discretion of this article's publisher. Write your comment with the following in mind to ensure the highest likelihood of it being approved:
- No promotional undertones
- No use of profanity
- Good spelling, grammar and layout
- Check punctuation, language and missing words
- No use of aggression
- No unsubstantiated claims
We reserve the right to remove comments at our discretion.
Your name is used alongside Comments.